DOI: 10.21276/ajptr
Mon, 27 May 2019


Dinesh Sachdeva*1,2 Anil Bhandari2


1. Registrar, Rajasthan Pharmacy Council, Sardar Patel Marg, Jaipur, Rajasthan, India.

2. Dean, Faculty of Pharmaceutical Sciences, Jodhpur National University, Jodhpur, Rajasthan, India.



Beta-blockers are the first line drugs in lowering the elevated and normal intraocular pressure associated with neuropathy of glaucoma, but for many reasons the use of this group of drugs requires supportive medications. The systemic side effects due to overdose of these drugs leads to pathetic complications in patients suffering with cardiac and pulmonary diseases. This article provides necessary information for the safe use of beta-blockers with detailed information about the disease glaucoma. Recent advances in the glaucoma therapy with beta-blockers and novel drug delivery systems developed are reviewed in this study.


Key words: Glaucoma, beta-blockers, intraocular pressure, Timolol, Levobunolol

[PDF]   Viewed: 1760   Downloaded: 136
  • Call for paper

    American Journal of PharmTech Research (AJPTR) is a peer-reviewed, bimonthly official international journal allowing access to abstracts and full-text.



  • Email & SMS Alerts

    Email/SMS alert system is one of the key features and gives update information about the submitted manuscript.


  • Article Statastics

    American Journal of PharmTech Research (AJPTR) provides unique facility for authors to know popularity of articles on basis of numbers of PDF download and views. It will display in tabulated format.

  • Online Submission

    American Journal of PharmTech Research (AJPTR) is one of the International open access journal devoted to various disciplines in science and technology.


web counter
web counter